PubMed Health⌕ Search

Biomedical subjects

A Gottwald

Publications and source records attributed to A Gottwald.

15 recordsLinked to original sources

The efficacy of inhibitors involved in spermidine metabolism in Plasmodium falciparum, Anopheles stephensi and Trypanosoma evansi.

In the present study, we have tested the effect of different polyamine inhibitors of the spermidine metabolizing enzymes deoxyhypusine synthase and homospermidine synthase in different chloroquine resistant Plasmodium falciparum strains, in the mosquito Anopheles stephensi (Diptera: Culicidae) and in a Trypanosoma evansi clone I from strain STIB 806 K China. Recent experiments have shown that agmatine is a growth inhibitor of the malaria parasite P. falciparum (Kaiser et al. 2001) in vitro. A comparison of agmatine efficacy with the new antimalarials artemisinin, triclosan and conventional chloroquine showed similar or even better results on the basis of growth inhibition and the reduction of developmental forms. However, no effect of triclosan or agmatine was observed at the ribonucleic acid level. In a second set of experiments, we tested the effect of 1,7-diaminoheptane and agmatine on oocyst formation in A. stephensi after infection with Plasmodium yoelii. Agmatine had an antisporozoite effect since 1,000 microM led to a 59.5% inhibition of oocysts. A much weaker inhibitor of oocyst formation was 1,7-diaminoheptane. The most effective in in vitro inhibition of T. evansi was dicyclohexylamine, an inhibitor of spermidine biosynthesis with an IC(50 ) value of 47.44 microM and the deoxyhypusine inhibitor 1,7-diaminoheptane with an IC(50) value of 47.80 microM. However, both drugs were ineffective in in vivo experiments in a Trypanosoma mouse model. Two different spermidine analogues, 1,8-diaminooctane and 1,3-diaminopropane with IC(50) values of 171 microM and 181.37 microM, respectively, were moderate inhibitors in vitro and ineffective in vivo.

Animals↗

Targeting enzymes involved in spermidine metabolism of parasitic protozoa--a possible new strategy for anti-parasitic treatment.

Sequencing data obtained from the Plasmodium, Anopheles gambiae and human genome projects provide a new basis for drug and vaccine development. One of the most characteristic features in the process of drug development against parasitic protozoa is target identification in a biological pathway. The next step must be a structure-based rational drug design if the target is not only present in the parasite. In mouse models of malaria, such drugs should be tested for efficacy of the new therapies. Here, we present data that pinpoint the existence of two enzymes of the polyamine pathway involved in spermidine metabolism in P. falciparum, i.e. deoxyhypusine synthase (DHS; EC 1.1.1.249) and homospermidine synthase (HSS; EC 2.5.1.45). Recent data obtained from the malaria genome databases showed that at least a putative gene encoding DHS is present in the parasite. Sequencing data from the P. falciparum genome project prove that the eukaryotic initiation factor eIF5A (the substrate for DHS) exists in P. falciparum. Here, we present the amino acid sequence of eIF5A from P. vivax, which causes tertiary malaria. EIF5A from P. vivax shows 82% nucleic acid and 97% amino acid identity to its homologue from P. falciparum. GC/MS data and inhibitor studies with agmatine prove that the triamine homospermidine occurs in the parasite. These data suggest a separate locus encoding HSS in P. falciparum. The hss gene recruits from the dhs gene in eukaryotes. Here, we present genomic DNA fragments obtained by amplification with primers of a conserved region (amino acid positions 550-1,043) between the putative P. falciparum DHS gene ( dhs) and the HSS gene ( hss) from the plant Senecio vulgaris (Asteraceae). The amplification product from different P. falciparum strains reveals differences in sequence identity, compared with the putative dhs gene from P. falciparum strain 3D7. Expression of the full-length clone and determination of HSS-specific activity will finally prove whether a separate region encoding HSS exists.

Alkyl and Aryl Transferases↗

Separation of velocity distribution and diffusion using PFG NMR.

Pulsed field gradient (PFG) NMR is applied to investigate flow processes. In this case the NMR signal experiences phase modulation due to flow and signal attenuation due to the distribution of velocities. The velocity distribution consists of one part originating from diffusion and of a second part, the distribution of the directed motion. The usual PFG-experiment in which the gradient strength is incremented cannot distinguish between both. Incrementing velocity at constant gradient strength keeps the contribution from diffusion constant but changes the absolute width of the velocity distribution. So the signal is attenuated again, but only due to the distribution of the directed motion. The phase modulation as a signature of flow is not affected by this strategy, because velocity and gradient strength are Fourier conjugated. The key advantage of this approach is the possibility of measuring very low velocities, which only cause a very slight phase modulation that is easily covered by diffusion. The method is discussed here for very slow flow in a rheometer cell.

Journal Article↗

The necessity to develop drugs against parasitic diseases.

This review focuses on the most significant trends in the development of drugs for the treatment of malaria, African sleeping sickness and toxoplasmosis. In the case of malaria, those include new fixed-dose artemisinin combinations, antifolates and new targets in the apicoplast of Plasmodium falciparum. Targets in the treatment of trypanosomiasis are the biosynthesis of glycosylphosphatidylinositol and enzymes involved in the biosynthesis of trypanothione. Efforts to develop a vaccine against toxoplasmosis are discussed as well.

Animals↗

Effect of drugs inhibiting spermidine biosynthesis and metabolism on the in vitro development of Plasmodium falciparum.

Treatment of Plasmodium falciparum with the potent inhibitor dicyclohexylamine completely arrests in vitro cell proliferation of the chloroquine-susceptible P. falciparum strain NF54 and the R strain, which shows less sensivity to chloroquine. The average inhibitory concentration (IC50) values determined for both strains revealed different inhibition profiles. The IC50 value for the chloroquine-sensitive NF54 strain was 97 microM and 501 microM for the R strain. Monitoring polyamine pools after treatment with dicyclohexylamine leads to a significant decrease in the intracellular spermidine content, which was nearly reversed by supplementation with spermidine. Since spermidine is an important precursor for the biosynthesis of hypusine and homospermidine in eukaryotes, we studied the developmental effect on both P. falciparum strains of 1,7-diaminoheptane as an inhibitor of deoxyhypusine synthase (EC 1.1.1.249) in mammalian cells, and agmatine as a moderate inhibitor of homospermidine synthase (EC 2.5.1.44). Inhibition profiles with 1,7-diaminoheptane resulted in an IC50 value of 466 microM for the NF54 strain and 319 microM for the R strain. Spermidine pools changed significantly. Inhibition with agmatine caused a strong decrease in parasitemia for the chloroquine-susceptible NF54 strain, with a determined IC50 value of 431 microM and an IC50 value of 340 microM for the less chloroquine-susceptible R strain. Spermidine was not detectable after inhibition. The uncommon triamine homospermidine occurred in both P. falciparum strains. To our knowledge this is the first evidence of homospermidine in P. falciparum. The use of specific inhibitors of spermidine metabolism might be a novel strategy for the design of new antimalarials, and suggests the occurrence of both enzymes in the parasite.

Agmatine↗

Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.

The response rates in metastatic renal cell cancer (RCC) after chemotherapy, hormonal treatment, or immunotherapy rarely exceed 15%. Recently, interferon alpha (IFN alpha) was used for treatment of this disease in several studies which also demonstrated response rates of 15%. In order to test whether IFN therapy combined with hormones would result in higher response rates we compared single agent IFN therapy with a combined therapy of rIFN alpha 2C plus medroxyprogesterone acetate (MPA) in a randomized multicenter trial. The rIFN alpha 2C (2MU) was given s.c. 5 times per week for 8-12 weeks and subsequently once weekly until week 48. In the combined treatment, 750 mg MPA was given p.o. daily until week 48 in addition to the IFN as described. The overall response rate in 93 evaluable patients was 5.4% corresponding to 2 complete and 3 partial responses. Median survival was 7 months in both treatment groups. These data confirm the ineffectivity of low IFN doses for treatment of RCC. The low response rate is not increased by addition of MPA to IFN. The analysis of other IFN studies suggests that not only IFN doses but also IFN sources may influence response rates in metastatic RCC.

Antineoplastic Combined Chemotherapy Protocols↗

Nonverbal expressiveness and EMG activity in tension headache sufferers and controls.

This study explored the relationship between musculoskeletal responses and nonverbal expressiveness in response to psychosocial stress. Muscle-contraction headache subjects and normal controls were confronted with a psychological stressor while forehead and neck EMG activity were recorded. Indices of nonverbal expressiveness (head and hand movements, facial tension, facial activity, and facial expressiveness) were obtained concomitantly with the muscle data. The headache subjects showed greater muscle activation than the controls in response to stress, greater evidence of facial tension, and less evidence of facial and bodily expressiveness. Overall, these data provided support for the notion that under some conditions a negative relationship exists between expressiveness and somatic activation.

Adult↗

[New aspects in the treatment of Scheuermann's disease with hippotherapy (author's transl)].

It had already been shown by clinical and x-ray examinations that various types of riding therapy exercise a favourable influence on the shape of the vertebral column. This has now been confirmed by means of analytical movement studies. Whereas the active exercises in riding therapy strengthen the musculature, especially in the region of the trunk, hippotherapy deserves special attention, since it has a considerable influence on the removal or at least reduction of segment fixation of the various parts of the spinal column. This form of therapy, as part of physiotherapy, is absolutely indispensable since it achieves a multitude of therapeutic aims. It is pointed out that hippotherapy does not involve any risk of damaging the intervertebral disks as a result of pressure.

Biomechanical Phenomena↗

[Parasites of the GDR. 3. Endoparasites of the hare (Lepus europeus)].

96 Hares from the eastern region of the Dresden district were examined for endoparasites and the results compared with those of other authors from GDR and the neighbouring countries. Out of the 27 endoparasites which up till now are recorded in the middle european region in GDR are found 6 Coccidia-spp.: Eimeria leporis, E. robertsoni, E. townsendi, E. semisculpta, E. europaea, E. hungarica and the helminths: Fasciola hepatica, Dicrocoelium dendriticum, Cittotaenia denticulata, Andrya rhopalocephala, Mosgovoyia pectinata, Cysticercus pisiformis, Graphidium strigosum, Trichostrongylus retortaeformis, Strongyloides papillosus, Passalurus ambiguus, Trichuris leporis, T. sylvilagus and Protostrongylus pulmonalis. The infection-extensity and -intensity is discussed in relation to the density of hare population and the ecological situation in the hunting-grounds.

Animals↗